Skip to content
Search

Latest Stories

Primary care networks play vital role in fighting Covid, report says

Primary care networks (PCNs) has played a significant role in combating the coronavirus pandemic in the UK, according to a report on the progress made and challenges faced by networks in the first two years of their five-year contract.

The report, based on a series of engagement sessions, hosted by the PCN Network, and a survey of more than 150 PCN clinical directors and PCN managers, was released by the NHS Confederation on Monday (2).


“Just two years on from their creation, they have risen to the challenges presented by the pandemic, administering the majority of vaccinations, reaching out to underserved communities and making headway against their objective to tackle health inequalities,” the report said.

Despite high workload during the pandemic PCNs’ profile has increased, leading to greater awareness of the services they offer and strengthening of relationships with local partners.

They helped in workforce development along with leadership capability and retention.

The report noted that PCNs are developing creative ways to reach underserved communities, tackle health inequalities and manage population health.

Highlighting the challenges faced by PCNs, the report said, “More than nine in ten survey respondents said their workload was greater than expected, with the consistently high workload derailing PCNs’ existing and planned work programmes.

“New service specifications are causing confusion over the purpose of PCNs, while a lack of consistent infrastructure was seen as hindering progress. Tensions were also identified with some local partners.”

A similar report on one-year performance of PCNs was released in July 2020, which identified three principles for NHS England and NHS Improvement (NHSEI) to consider when developing PCN policy.

The three principles were - PCNs having autonomy over their resources and influence over policies determining their future, as well as within integrated care systems (ICSs); a flexible approach to be factored into their development; and for the shift towards ICSs to be accompanied by streamlined processes for PCNs. These principles have informed PCN policy over the past year, especially with regards to the health and care bill and ICS guidance.

“We encourage NHSEI to use these principles to underpin the development of PCN policy and all policies that impact PCNs,” it said.

The 2021-22 network Direct Enhanced Services (DES) addressed some of the asks, that have not been resolved fully and remain relevant.

“Through continuing engagement with clinical directors and PCN managers, we will develop specific asks for the 2022-23 network contract DES in the autumn, relating to workload management; funding for PCN leadership and management; certainty around funding streams and contractual arrangements; and consistent and streamlined processes,” it said.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less